Merck & Co expands discovery alliance with Galapagos

Merck & Co Inc has expanded its research alliance with Galapagos NV of Belgium to include the discovery of potential small molecule drugs in atherosclerosis. This raises the potential milestones from the alliance to €400 million, Galapagos said.